Host |
Monospecific Mouse |
Klon |
ZM61 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Tonsil. |
Verdünnung |
- |
Isotyp |
IgG2b /κ |
Verdünnung |
Recombinant human CD5 protein fragment (around aa 269-366) (exact sequence is proprietary) |
Lokalisation |
Cell membrane |
CD5
|
Zeta Corporation |
ZM61 |
7 ml |
Ready-to-use |
CE/IVD |
Z2371MP |
-
|
Host |
Monospecific Mouse |
Klon |
ZM61 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Tonsil. |
Verdünnung |
1:50 - 1:100 |
Isotyp |
IgG2b /κ |
Verdünnung |
Recombinant human CD5 protein fragment (around aa 269-366) (exact sequence is proprietary) |
Lokalisation |
Cell membrane |
CD5
|
Zeta Corporation |
ZM61 |
0.5 ml |
Concentrate |
CE/IVD |
Z2371MS |
-
|
Host |
Monospecific Mouse |
Klon |
ZM61 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Tonsil. |
Verdünnung |
1:50 - 1:100 |
Isotyp |
IgG2b /κ |
Verdünnung |
Recombinant human CD5 protein fragment (around aa 269-366) (exact sequence is proprietary) |
Lokalisation |
Cell membrane |
CD5
|
Zeta Corporation |
ZM61 |
0.1 ml |
Concentrate |
CE/IVD |
Z2371MT |
-
|
Host |
Mouse |
Klon |
ZM213 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Tonsil or lymph node. |
Verdünnung |
1:50 - 1:100 |
Isotyp |
IgG1 /κ |
Verdünnung |
Recombinant human full-length CD7 protein |
Lokalisation |
Cell membrane |
CD7
|
Zeta Corporation |
ZM213 |
1.0 ml |
Concentrate |
CE/IVD |
Z2548ML |
-
|
Host |
Mouse |
Klon |
ZM213 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Tonsil or lymph node. |
Verdünnung |
- |
Isotyp |
IgG1 /κ |
Verdünnung |
Recombinant human full-length CD7 protein |
Lokalisation |
Cell membrane |
CD7
|
Zeta Corporation |
ZM213 |
7 ml |
Ready-to-use |
CE/IVD |
Z2548MP |
-
|
Host |
Mouse |
Klon |
ZM213 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Tonsil or lymph node. |
Verdünnung |
1:50 - 1:100 |
Isotyp |
IgG1 /κ |
Verdünnung |
Recombinant human full-length CD7 protein |
Lokalisation |
Cell membrane |
CD7
|
Zeta Corporation |
ZM213 |
0.5 ml |
Concentrate |
CE/IVD |
Z2548MS |
-
|
Host |
Mouse |
Klon |
ZM213 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Tonsil or lymph node. |
Verdünnung |
1:50 - 1:100 |
Isotyp |
IgG1 /κ |
Verdünnung |
Recombinant human full-length CD7 protein |
Lokalisation |
Cell membrane |
CD7
|
Zeta Corporation |
ZM213 |
0.1 ml |
Concentrate |
CE/IVD |
Z2548MT |
-
|
Host |
Mouse |
Klon |
C8/144B |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil, normal colon |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 kappa |
Lokalisation |
Cell membrane |
CD8
|
Biocare Medical |
C8/144B |
0.1 ml |
Concentrate |
CE/IVD |
ACI3160A |
-
|
Host |
Mouse |
Klon |
C8/144B |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil, normal colon |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 kappa |
Lokalisation |
Cell membrane |
CD8
|
Biocare Medical |
C8/144B |
1 ml |
Concentrate |
CE/IVD |
ACI3160C |
-
|
Host |
Rabbit |
Klon |
C8/1779R |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG kappa |
Verdünnung |
Recombinant full-length human CD8 protein |
Lokalisation |
Cell surface |
CD8
|
Biocare Medical |
C8/1779R |
0.1 ml |
Concentrate |
CE/IVD |
ACI3219A |
-
|
Host |
Rabbit |
Klon |
C8/1779R |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG kappa |
Verdünnung |
Recombinant full-length human CD8 protein |
Lokalisation |
Cell surface |
CD8
|
Biocare Medical |
C8/1779R |
1 ml |
Concentrate |
CE/IVD |
ACI3219C |
-
|
Host |
Mouse |
Klon |
C8/144B |
Format |
Ready-to-use |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil, normal colon |
Verdünnung |
- |
Isotyp |
IgG1 kappa |
Lokalisation |
Cell membrane |
CD8
|
Biocare Medical |
C8/144B |
6 ml |
Ready-to-use |
CE/IVD |
API3160AA |
-
|
Host |
Rabbit |
Klon |
C8/1779R |
Format |
Ready-to-use |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
Rabbit IgG kappa |
Verdünnung |
Recombinant full-length human CD8 protein |
Lokalisation |
Cell surface |
CD8
|
Biocare Medical |
C8/1779R |
6 ml |
Ready-to-use |
CE/IVD |
API3219AA |
-
|
Host |
Mouse |
Klon |
144B |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
144B |
1 ml |
Concentrate |
CE/IVD |
MOB117 |
-
|
Host |
Mouse |
Klon |
144B |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
144B |
0.1 ml |
Concentrate |
CE/IVD |
MOB117-01 |
-
|
Host |
Mouse |
Klon |
144B |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:25 - 1:50 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
144B |
0.5 ml |
Concentrate |
CE/IVD |
MOB117-05 |
-
|
Host |
Mouse |
Klon |
144B |
Format |
Ready-to-use |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
144B |
6 ml |
Ready-to-use |
CE/IVD |
PDM094 |
-
|
Host |
Rabbit |
Klon |
SP16 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
SP16 |
1 ml |
Concentrate |
CE/IVD |
RMAB012 |
-
|
Host |
Rabbit |
Klon |
SP16 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
SP16 |
0.1 ml |
Concentrate |
CE/IVD |
RMAB012-01 |
-
|
Host |
Rabbit |
Klon |
SP16 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 |
Isotyp |
Rabbit IgG |
Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
SP16 |
0.5 ml |
Concentrate |
CE/IVD |
RMAB012-05 |
-
|
Host |
Rabbit |
Klon |
SP16 |
Format |
Ready-to-use |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
Rabbit IgG |
Lokalisation |
Cell Membrane |
CD8
|
Diagnostic Biosystems |
SP16 |
6 ml |
Ready-to-use |
CE/IVD |
RMPD012 |
-
|
Host |
Mouse |
Klon |
ZM54 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Lymph node. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Human CD8 recombinant protein |
Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZM54 |
1.0 ml |
Concentrate |
CE/IVD |
Z2364ML |
-
|
Host |
Mouse |
Klon |
ZM54 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Lymph node. |
Verdünnung |
- |
Isotyp |
IgG1 /κ |
Verdünnung |
Human CD8 recombinant protein |
Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZM54 |
7 ml |
Ready-to-use |
CE/IVD |
Z2364MP |
-
|
Host |
Mouse |
Klon |
ZM54 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Lymph node. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Human CD8 recombinant protein |
Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZM54 |
0.5 ml |
Concentrate |
CE/IVD |
Z2364MS |
-
|
Host |
Mouse |
Klon |
ZM54 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Positivkontrolle |
Lymph node. |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG1 /κ |
Verdünnung |
Human CD8 recombinant protein |
Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZM54 |
0.1 ml |
Concentrate |
CE/IVD |
Z2364MT |
-
|
Host |
Monospecific Rabbit |
Klon |
ZR286 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
Human CD8 recombinant protein |
Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZR286 |
1 ml |
Concentrate |
CE/IVD |
Z2601RL |
-
|
Host |
Monospecific Rabbit |
Klon |
ZR286 |
Format |
Ready-to-use |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
IgG |
Verdünnung |
Human CD8 recombinant protein |
Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZR286 |
7 ml |
Ready-to-use |
CE/IVD |
Z2601RP |
-
|
Host |
Monospecific Rabbit |
Klon |
ZR286 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
Human CD8 recombinant protein |
Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZR286 |
0.5 ml |
Concentrate |
CE/IVD |
Z2601RS |
-
|
Host |
Monospecific Rabbit |
Klon |
ZR286 |
Format |
Concentrate |
Reaktivität |
- |
Methode |
P |
Vorbehandlung |
Citrate or EDTA |
Positivkontrolle |
Tonsil |
Verdünnung |
1:100 - 1:200 |
Isotyp |
IgG |
Verdünnung |
Human CD8 recombinant protein |
Lokalisation |
Cell membrane |
CD8
|
Zeta Corporation |
ZR286 |
0.1 ml |
Concentrate |
CE/IVD |
Z2601RT |
-
|
Host |
Mouse |
Klon |
LT8 |
Format |
Purified |
Methode |
F, IP, FL |
Isotyp |
Mouse IgG1 |
Verdünnung |
Normal human peripheral blood lymphocytes |
CD8 (T-Cell cytotoxic/suppressor)
|
Zytomed Systems GmbH |
LT8 |
200 µg |
Purified |
RUO |
603-0342 |
-
|
Host |
Mouse |
Klon |
4B11 |
Format |
Lyophilised |
Methode |
F, P, WB |
Vorbehandlung |
EDTA |
Positivkontrolle |
Human Tonsil |
Verdünnung |
1:20 - 1:40 (P) |
Isotyp |
Mouse IgG2b |
Verdünnung |
Synthetic peptide derived from CD8 alpha chain sequence |
CD8 (T-Cell cytotoxic/suppressor)
|
Zytomed Systems GmbH |
4B11 |
1 ml |
Lyophilised |
RUO |
603-0346 |
-
|
Host |
Mouse |
Klon |
LT8 |
Format |
Purified |
Methode |
F, IP, FL |
Isotyp |
Mouse IgG1 |
Verdünnung |
Normal human peripheral blood lymphocytes |
CD8 (T-Cell cytotoxic/suppressor)
|
Zytomed Systems GmbH |
LT8 |
100 µg |
Purified |
RUO |
603-1226 |
-
|
Host |
Rat |
Klon |
YTS105.18 |
Format |
Purified |
Methode |
F, FL |
Isotyp |
Rat IgG2a |
Verdünnung |
Mouse spleen cells |
CD8 (T-Cell cytotoxic/suppressor) (Low Endotoxin)
|
Zytomed Systems GmbH |
YTS105.18 |
500 µg |
Purified |
RUO |
603-2334 |
-
|
Host |
Mouse |
Klon |
MM2/57 |
Format |
Purified |
Methode |
F, WB, FL |
Isotyp |
Mouse IgG2b |
Verdünnung |
Human platelet membrane |
CD9 (Motility-Related Protein-1)
|
Zytomed Systems GmbH |
MM2/57 |
100 µg |
Purified |
RUO |
603-0412 |
-
|
Host |
Rabbit |
Klon |
SP67 |
Format |
Concentrate |
Reaktivität |
BV, CK, MS, RT |
Methode |
P, WB |
Vorbehandlung |
EDTA |
Verdünnung |
1:100 |
Verdünnung |
Synthetic peptide corresponding to human CD10 |
CD10 (CALLA)
|
Zytomed Systems GmbH |
SP67 |
0.1 ml |
Concentrate |
RUO |
503-3670 |
-
|
Host |
Rabbit |
Klon |
SP67 |
Format |
Concentrate |
Reaktivität |
BV, CK, MS, RT |
Methode |
P, WB |
Vorbehandlung |
EDTA |
Verdünnung |
1:100 |
Verdünnung |
Synthetic peptide corresponding to human CD10 |
CD10 (CALLA)
|
Zytomed Systems GmbH |
SP67 |
0.5 ml |
Concentrate |
RUO |
503-3672 |
-
|
Host |
Rabbit |
Klon |
SP67 |
Format |
Concentrate |
Reaktivität |
BV, CK, MS, RT |
Methode |
P, WB |
Vorbehandlung |
EDTA |
Verdünnung |
1:100 |
Verdünnung |
Synthetic peptide corresponding to human CD10 |
CD10 (CALLA)
|
Zytomed Systems GmbH |
SP67 |
1 ml |
Concentrate |
RUO |
503-3674 |
-
|
Host |
Mouse |
Klon |
UMAB236 |
Format |
RTU |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Normal kidney and tonsil |
Verdünnung |
- |
Isotyp |
Mouse IgG1 |
Verdünnung |
Human recombinant protein of CD10 |
Lokalisation |
Cytoplasm (kidney) and cell membrane (tonsil) |
CD10 (CALLA)
|
Biocare Medical |
UMAB236 |
6 ml |
RTU |
CE/IVD |
API3212AA |
-
|
Host |
Mouse |
Klon |
56C6 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:20 - 1:30 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cell Membrane |
CD10 (CALLA)
|
Diagnostic Biosystems |
56C6 |
1 ml |
Concentrate |
CE/IVD |
MOB240 |
-
|
Host |
Mouse |
Klon |
56C6 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:20 - 1:30 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cell Membrane |
CD10 (CALLA)
|
Diagnostic Biosystems |
56C6 |
0.1 ml |
Concentrate |
CE/IVD |
MOB240-01 |
-
|
Host |
Mouse |
Klon |
56C6 |
Format |
Concentrate |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
1:20 - 1:30 |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cell Membrane |
CD10 (CALLA)
|
Diagnostic Biosystems |
56C6 |
0.5 ml |
Concentrate |
CE/IVD |
MOB240-05 |
-
|
Host |
Mouse |
Klon |
56C6 |
Format |
Ready-to-use |
Methode |
F, P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil |
Verdünnung |
- |
Isotyp |
Mouse IgG1 |
Lokalisation |
Cell Membrane |
CD10 (CALLA)
|
Diagnostic Biosystems |
56C6 |
6 ml |
Ready-to-use |
CE/IVD |
PDM107 |
-
|
Host |
Rabbit |
Klon |
EP195 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil, renal cell carcinoma, follicular lymphoma |
Verdünnung |
1:50 - 1:100 |
Isotyp |
Rabbit IgG |
Verdünnung |
A recombinant fragment corresponding to residues in human CD10 protein |
Lokalisation |
Cell membrane, Cytoplasm |
CD10 (CALLA)
|
Diagnostic Biosystems |
EP195 |
1 ml |
Concentrate |
CE/IVD |
RMAB037 |
-
|
Host |
Rabbit |
Klon |
EP195 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil, renal cell carcinoma, follicular lymphoma |
Verdünnung |
1:50 - 1:100 |
Isotyp |
Rabbit IgG |
Verdünnung |
A recombinant fragment corresponding to residues in human CD10 protein |
Lokalisation |
Cell membrane, Cytoplasm |
CD10 (CALLA)
|
Diagnostic Biosystems |
EP195 |
0.1 ml |
Concentrate |
CE/IVD |
RMAB037-01 |
-
|
Host |
Rabbit |
Klon |
EP195 |
Format |
Concentrate |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil, renal cell carcinoma, follicular lymphoma |
Verdünnung |
1:50 - 1:100 |
Isotyp |
Rabbit IgG |
Verdünnung |
A recombinant fragment corresponding to residues in human CD10 protein |
Lokalisation |
Cell membrane, Cytoplasm |
CD10 (CALLA)
|
Diagnostic Biosystems |
EP195 |
0.5 ml |
Concentrate |
CE/IVD |
RMAB037-05 |
-
|
Host |
Rabbit |
Klon |
EP195 |
Format |
Ready-to-use |
Methode |
P |
Vorbehandlung |
Citrate |
Positivkontrolle |
Tonsil, renal cell carcinoma, follicular lymphoma |
Verdünnung |
- |
Isotyp |
Rabbit IgG |
Verdünnung |
A recombinant fragment corresponding to residues in human CD10 protein |
Lokalisation |
Cell membrane, Cytoplasm |
CD10 (CALLA)
|
Diagnostic Biosystems |
EP195 |
6 ml |
Ready-to-use |
CE/IVD |
RMPD037 |
-
|
Host |
Mouse |
Klon |
OX-42 |
Format |
Purified |
Methode |
F, IP, FL |
Isotyp |
Mouse IgG2a |
Verdünnung |
Rat peritoneal macrophages |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
OX-42 |
100 µg |
Purified |
RUO |
603-0455 |
-
|
Host |
Mouse |
Klon |
ICRF44 |
Format |
Purified |
Methode |
F, IP, FL |
Isotyp |
Mouse IgG1 |
Verdünnung |
Rheumatoid synovial cells and human monocytes |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
ICRF44 |
200 µg |
Purified |
RUO |
603-0457 |
-
|
Host |
Mouse |
Klon |
ICRF44 |
Format |
Purified |
Methode |
F, IP, FL |
Isotyp |
Mouse IgG1 |
Verdünnung |
Rheumatoid synovial cells and human monocytes |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
ICRF44 |
100 µg |
Purified |
RUO |
603-0458 |
-
|
Host |
Mouse |
Klon |
ICRF44 |
Format |
Purified |
Methode |
F, FL |
Isotyp |
Mouse IgG1 |
Verdünnung |
Rheumatoid synovial cells and human monocytes |
CD11b (alpha M integrin)
|
Zytomed Systems GmbH |
ICRF44 |
20 µg |
Purified |
RUO |
603-0459 |
-
|